Drug interaction of isotretinoin and protease inhibitors: support for the cellular retinoic acid-binding protein-1 theory of lipodystrophy?
Padberg
J
J
Schürmann
D
D
Grobusch
M
M
Bergmann
F
F
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects*; D007641:Keratolytic Agents / Q000009:adverse effects*; D008060:Lipodystrophy / Q000139:chemically induced*; D008297:Male; D018168:Receptors, Retinoic Acid / Q000378:metabolism*
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D007641:Keratolytic Agents; D018168:Receptors, Retinoic Acid; C082927:retinoic acid binding protein I, cellular; D015474:Isotretinoin